B
Bull
Bull · 25%OSCR
$20.09
Szenariopreis
$30.470
+0.427 (+1.40%)Zum Schluss
Loading chart…
- High
- 31.510
- Open
- 30.000
- VWAP
- 30.41
- Vol
- 5.18M
- Mkt Cap
- 4.19B
- Low
- 29.240
- Amount
- 157.54M
- EV/EBITDA, TTM
- 3.43
Oscar Health, Inc. is a healthcare technology company built around a full-stack technology platform. The Company serves individuals, families, and employees through the Patient Protection and Affordable Care Act (ACA). It also offers health technology solutions that power the healthcare industry through +Oscar. It also wholly owns three businesses operating in the individual market: Lucie, Inc., a technology enrollment platform for consumers, employers and brokers; Trove Group Inc., an insurance agency that sells individual medical and supplemental health products, and HealthInsurance.org, LLC, a lead generation website providing educational content to help consumers navigate health insurance as well as the ACA and Medicare marketplaces.
AI analysis of Oscar Health Inc (OSCR)
holdOscar Health Inc is currently priced at $30.47, which is above its recent support level of $29.725 but below the Fibonacci resistance level of $31.371. The RSI is at 44.461, indicating that the stock is approaching oversold territory, which could present a buying opportunity if momentum shifts. However, the forward P/E ratio is extremely high at 588.24, suggesting that the stock may be overvalued at this price. Additionally, the recent 5-day change is down 4.90%, indicating short-term weakness. The main risk is the mixed analyst sentiment, with targets ranging from $27 to $39, reflecting uncertainty about future performance.
Bewertungskennzahlen
The current forward P/E ratio for Oscar Health Inc (OSCR) is 588.24, compared to its 5-year average forward P/E of 108.06.
Alphio AI Price Scenarios for OSCR
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding OSCR
Event-Zeitleiste
News
4.508-19Yahoo FinanceBiotech Gains Propel S&P 500 and Nasdaq Slightly Higher
4.508-19FoolOscar Health Integrates AI to Enhance Operations
7.508-19NASDAQ.COMOscar Health Integrates AI to Enhance Operations
7.508-17stocktwitsOscar Partners with Hims for Retail Drug Sales
4.508-17Yahoo FinanceS&P 500 and Nasdaq Poised for Rally
OSCR FAQ — answered by Alphio AI
Oscar Health, Inc. is a healthcare technology company built around a full-stack technology platform. The Company serves individuals, families, and employees through the Patient Protection and Affordable Care Act (ACA). It also offers health technology solutions that power the healthcare industry through +Oscar. It also wholly owns three businesses operating in the individual market: Lucie, Inc., a technology enrollment platform for consumers, employers and brokers; Trove Group Inc., an insurance agency that sells individual medical and supplemental health products, and HealthInsurance.org, LLC, a lead generation website providing educational content to help consumers navigate health insurance as well as the ACA and Medicare marketplaces. It operates in the Financials sector (HOSPITAL & MEDICAL SERVICE PLANS industry).
Oscar Health Inc is currently priced at $30.47, which is above its recent support level of $29.725 but below the Fibonacci resistance level of $31.371. The RSI is at 44.461, indicating that the stock is approaching oversold territory, which could present a buying opportunity if momentum shifts. However, the forward P/E ratio is extremely high at 588.24, suggesting that the stock may be overvalued at this price. Additionally, the recent 5-day change is down 4.90%, indicating short-term weakness. The main risk is the mixed analyst sentiment, with targets ranging from $27 to $39, reflecting uncertainty about future performance.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.